1Koenig W.Fibrin (ogeh) in cardiovascular disease;an update. Thromb Haemost.2003Apr;89(4):601-9.
2Fukujima MM, Martinez TL,Pinto LE,et al.Fibrinogen as independent risk factor for ischemic stroke. Arq Neuropsiquiatr,1997,55(4):737-740.
3Tribouilloy C, Pehier M, Colas L, et al.Fibrinogen is an independent marker for thoracic aortic atherosolerosis. Am J Cardiol,1998,81(3):321-326.
4Szapary L, Horvath B,Marton2, et al.Hemorheological disturbances in patients with chronic eerebrovaseoular diseases. Clin Hemorheol Miereeire.2004:31(1):1-9.
5Kain K,Catto A J, Grant PJ. Impaired fibrinolysis and increased fibrinogen levels in south Asian subjects. Atheroselerosis,2001,156 (2):457-461.
6Sakakibara H, Fujii C,Naito M.Plasma fibrinogen and its association with cardiovascular risk factors in apparently healthy Japanese subjects. Heart essels.2004 May;19(3):144-8.
7Naito M. Effects of fibrinogen, fibrin and their degradation products on the behaviour of vascular smooth muscle cells. Nippon Ronen Lgakkai Lasshi,2000,37(6):458-463.
8Naitom,Hayashi T,IguchiA.New approaches to the prevention of atherosclerosis.Drugs, 1995,50(3):440-453.
9Willeit J,Kicchl S,Oberhol lenzer F,et al.Distinct risk profiles of early and advanced atherosclerosis:prospective results from the Bruneck Study.Arterioscler Thromb Vase Biol,2000,20(2):529-537.
10Symonides B,Januszewicz A,Rowinski O,et al.Plasma fibrinogen as a risk factor for restenosis afetr percutaneous transluminal renal angioplasty in patients with atherosclerotic rcnal.artery stenosis.J Cardiovasc Risk,1999,6(4):269-272.
